Vaccine Data CoLab Phase 2: Improving COVID-19 vaccine uptake, with a view to build resilient health systems for future shocks
- Funded by Foreign, Commonwealth & Development Office (FCDO)
- Total publications:0 publications
Grant number: GB-GOV-1-301168-114
Grant search
Key facts
Disease
COVID-19Start & end year
20222023Known Financial Commitments (USD)
$2,333,167.42Funder
Foreign, Commonwealth & Development Office (FCDO)Research Location
United KingdomLead Research Institution
DT Global International Development UK LtdResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilienceResearch Subcategory
Vaccine/Therapeutic/ treatment hesitancySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Phase 2 of the Vaccine Data CoLab will focus on catalysing COVID-19 vaccine uptake, with a view to build resilient health systems for future shocks. This approach moves beyond vaccine supply and works to provide data on the specific hesitancies and access barriers communities face. This requires moving from a global to a hyperlocal and targeted approach taking into account unique contexts and local planning and decision making for more effective behaviour change campaigns and vaccine strategies.